Heme/Hydrogen Peroxide ReactiVity
J. Am. Chem. Soc., Vol. 122, No. 50, 2000 12479
Scheme 2
in the meso hydroxylation of the heme.11-15 The major evidence
for initial heme hydroxylation has come from studies that show
that R-hydroxylated heme binds to heme oxygenase and can
replace heme as a substrate for heme oxygenase. However, only
recently has direct spectroscopic evidence been produced that
suggests that a meso-hydroxylated heme is formed by heme
oxygenase.16
The coupled oxidation process, in which heme degradation
is brought about by dioxygen in the presence of a reducing agent
(generally ascorbic acid), has been widely employed as a model
for biological heme catabolism.17-19 The coupled oxidation
procedure can be utilized to oxidize iron porphyrins as model
compounds20,21 or to oxidize intact heme proteins. Coupled
oxidation of heme alone produces a mixture of all four biliverdin
isomers as a result of reaction at all four meso positions.22
Moreover, the four isomers appear to be formed in nearly equal
proportions, and the process does not show the regiospecificity
displayed by heme oxygenase oxidation. However, with a
trifluoromethyl-substituted heme, 7-demethyl-7-(trifluorometh-
yl)mesohemin IX, an unusually high degree of regiospecificity
has been observed, and this specificity has been attributed to
electronic control of the process.23 Notably, coupled oxidation
of myoglobin, as well as an active site variant of myoglobin,
results in cleavage that occurs exclusively at the R-meso
carbon.24,25
which the meso substituent is deprotonated.19,26 This complex
has received considerable study27-30 and has recently been
isolated in pure form in this laboratory.31 (py)2Fe(OEPO) is
conveniently prepared by the addition of pyridine to the dimer,
{FeIII(OEPO)}2,32 in the absence of dioxygen as shown in
Scheme 2.33 While the crystallographic data on this species
indicate that the iron is in a high-spin state, the assignment of
the iron and ligand oxidation states in solutions of this complex
is less clear, since it can be described by a combination of the
three canonical structures shown as 1a, 1b, and 1c in Scheme
2. Spectroscopically, (py)2Fe(OEPO) is readily identified on the
1
basis of its characteristic H NMR spectrum which displays
marked upfield shifts for the two types of meso protons and
both upfield and downfield shifts for the methylene protons.
The regiospecificity of heme catabolism produced by heme
oxygenase and by coupled oxidation of myoglobin has been
ascribed to both steric and electronic factors.34,35 The effect of
meso-methyl versus meso-formyl substitution on the regiospeci-
ficity of HO reaction36,37 and the NMR observation38 of larger
spin density at R-meso position in HO have led to the conclusion
that electronic effects are important in regioselectivity. Recently,
the crystal structure of human heme oxygenase-1 with the
substrate (heme) bound has been reported.39 The heme is
sandwiched between two helical protein segments with the
proximal helix providing histidine 25 as an axial ligand. There
are two molecules of the heme/heme oxygenase complex in the
asymmetric unit. One of these molecules offers more confine-
ment of the heme with the distal helix restricting access to the
For coupled oxidation of (py)2FeII(OEP) in pyridine solution,
meso hydroxylation produces (py)2(FeOEPO), a compound in
(11) Yoshida, T.; Noguchi, M.; Kikuchi, G.; Sano, S. J. Biochem. 1981,
90, 125.
(12) Sano, S.; Sano, T.; Morishima, I.; Shiro, Y.; Maeda, Y. Proc. Natl.
Acad. Sci. U.S.A. 1986, 83, 531.
(26) Balch, A. L. Coord. Chem. ReV. 2000, 200-202, 349.
(27) Sano, S.; Sugiura, Y.; Maeda, Y.; Ogawa, S.; Morishima, I. J. Am.
Chem. Soc. 1981, 103, 2888.
(13) Wilks, A.; Ortiz de Montellano, P. R. J. Biol. Chem. 1993, 268,
22357.
(14) Wilks, A.; Torpey, J.; Ortiz de Montellano, P. R. J. Biol. Chem.
1994, 269, 29553.
(15) Mansfield Matera, K.; Takahashi, S.; Fujii, H.; Zhou, H.; Ishikawa,
K.; Yoshimura, T.; Rousseau, D. L.; Yoshida, T.; Ikeda-Saito, M. J. Biol.
Chem. 1996, 271, 6618.
(28) Morishima, I.; Fujii, H.; Shiro, Y. J. Am. Chem. Soc. 1986, 108,
3858.
(29) Morishima, I.; Shiro, Y.; Hiroshi, F. Inorg. Chem. 1995, 34, 1528.
(30) Balch, A. L.; Noll, B. C.; Reid, S. M.; Zovinka, E. P. Inorg. Chem.
1993, 32, 2610.
(31) Balch, A. L.; Koerner, R.; Latos-Graz˘yn´ski, L.; Noll, B. C. J. Am.
Chem. Soc. 1996, 118, 2760.
(16) Liu, Y.; Moe¨nne-Loccoz, P.; Loehr, T. M.; Ortiz de Montellano, P.
R. J. Biol. Chem. 1997, 272, 6909.
(32) Balch, A. L.; Latos-Graz˘yn´ski; Noll, B. C.; Olmstead, M. M.;
Zovinka, E. P. Inorg. Chem. 1992, 31, 2248.
(33) Balch, A. L.; Noll, B. C.; Reid, S. M.; Zovinka, E. P. Inorg. Chem.
1993, 32, 2610.
(34) O’Carra, P. In Porphyrins and Metalloporphyrins; Smith, K. M.,
Ed.; Elsevier Scientific Pub. Co.: New York, 1975; p 123.
(35) Brown, S. B.; Chabot, A. A.; Enderby E. A.; North A. C. T. Nature
1981, 289, 93.
(36) Torpey, J.; Ortiz de Montellano, P. R., J. Biol. Chem., 1996, 271,
26067.
(37) Torpey, J.; Ortiz de Montellano, P. R., J. Biol. Chem., 1997, 272,
22008.
(38) Herna´ndez, G.; Wilks, A.; Paolesse, R.; Smith K. M.; Ortiz de
Montellano, P. R.; La Mar, G. N. Biochemistry 1994, 33, 6631.
(39) Schuller, D.; Wilks, A.; Ortiz de Montellano, P. R.; Poulos T. Nature
Struct. Biol. 1999, 6, 861.
(17) Warburg, O.; Negelein, E. Chem. Ber. 1930, 63, 1816.
(18) Lagarias, J. C. Biochim. Biophys. Acta 1982, 717, 12.
(19) St Claire, T. N.; Balch, A. L. Inorg. Chem. 1999, 38, 684.
(20) Balch, A. L.; Latos-Graz˘yn´ski, L.; Noll, B. C.; Olmstead, M. M.;
Szterenberg, L.; Safari, N. J. Am. Chem. Soc. 1993, 115, 1422.
(21) Balch, A. L.; Latos-Graz˘yn´ski, L.; Noll, B. C.; Olmstead, M. M.;
Safari, N. J. Am. Chem. Soc. 1993, 115, 9056.
(22) Bonnett, R.; McDonagh, A. F. J. Chem. Soc., Perkin Trans. 1 1973,
881.
(23) Crusats, J.; Suzuki, A.; Mizutani, T.; Ogoshi, H., J. Org. Chem.
1998, 63, 602.
(24) O’Carra, P.; Colleran, E. FEBS Lett. 1969, 5, 295.
(25) Hildebrand, D. P.; Tang, H.; Luo, Y.; Hunter, C. L.; Smith, M.;
Brayer, G. D.; Mauk, A. G. J. Am. Chem. Soc. 1996, 118, 12909.